Logo image of RH

RH (RH) Stock Fundamental Analysis

USA - NYSE:RH - US74967X1037 - Common Stock

178.81 USD
-6.89 (-3.71%)
Last: 10/22/2025, 8:04:00 PM
180 USD
+1.19 (+0.67%)
After Hours: 10/22/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, RH scores 4 out of 10 in our fundamental rating. RH was compared to 119 industry peers in the Specialty Retail industry. There are concerns on the financial health of RH while its profitability can be described as average. RH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year RH was profitable.
RH had a positive operating cash flow in the past year.
RH had positive earnings in each of the past 5 years.
In the past 5 years RH always reported a positive cash flow from operatings.
RH Yearly Net Income VS EBIT VS OCF VS FCFRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

RH has a Return On Assets (2.27%) which is comparable to the rest of the industry.
The Return On Invested Capital of RH (8.46%) is better than 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RH is in line with the industry average of 12.29%.
Industry RankSector Rank
ROA 2.27%
ROE N/A
ROIC 8.46%
ROA(3y)4.87%
ROA(5y)7.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.73%
ROIC(5y)14.31%
RH Yearly ROA, ROE, ROICRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K

1.3 Margins

RH's Profit Margin of 3.20% is fine compared to the rest of the industry. RH outperforms 69.75% of its industry peers.
In the last couple of years the Profit Margin of RH has declined.
RH has a better Operating Margin (10.68%) than 84.03% of its industry peers.
RH's Operating Margin has declined in the last couple of years.
The Gross Margin of RH (44.61%) is better than 70.59% of its industry peers.
In the last couple of years the Gross Margin of RH has remained more or less at the same level.
Industry RankSector Rank
OM 10.68%
PM (TTM) 3.2%
GM 44.61%
OM growth 3Y-26.37%
OM growth 5Y-6.4%
PM growth 3Y-50.1%
PM growth 5Y-22.84%
GM growth 3Y-3.41%
GM growth 5Y1.47%
RH Yearly Profit, Operating, Gross MarginsRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), RH is creating some value.
The number of shares outstanding for RH has been increased compared to 1 year ago.
The number of shares outstanding for RH has been reduced compared to 5 years ago.
Compared to 1 year ago, RH has an improved debt to assets ratio.
RH Yearly Shares OutstandingRH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
RH Yearly Total Debt VS Total AssetsRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

RH has an Altman-Z score of 1.33. This is a bad value and indicates that RH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.33, RH is not doing good in the industry: 68.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACC0.83
WACC10.18%
RH Yearly LT Debt VS Equity VS FCFRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

RH has a Current Ratio of 1.26. This is a normal value and indicates that RH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RH (1.26) is comparable to the rest of the industry.
A Quick Ratio of 0.26 indicates that RH may have some problems paying its short term obligations.
With a Quick ratio value of 0.26, RH is not doing good in the industry: 83.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.26
RH Yearly Current Assets VS Current LiabilitesRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 347.80% over the past year.
RH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.46% yearly.
The Revenue has grown by 9.56% in the past year. This is quite good.
Measured over the past years, RH shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)347.8%
EPS 3Y-41.01%
EPS 5Y-14.46%
EPS Q2Q%73.37%
Revenue 1Y (TTM)9.56%
Revenue growth 3Y-5.41%
Revenue growth 5Y3.74%
Sales Q2Q%8.38%

3.2 Future

The Earnings Per Share is expected to grow by 47.65% on average over the next years. This is a very strong growth
RH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.41% yearly.
EPS Next Y73.57%
EPS Next 2Y57.8%
EPS Next 3Y49.48%
EPS Next 5Y47.65%
Revenue Next Year9.16%
Revenue Next 2Y9.65%
Revenue Next 3Y9.48%
Revenue Next 5Y8.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RH Yearly Revenue VS EstimatesRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
RH Yearly EPS VS EstimatesRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40 50

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.11, RH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, RH is valued a bit cheaper than the industry average as 66.39% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.57, RH is valued at the same level.
With a Price/Forward Earnings ratio of 13.42, RH is valued correctly.
Based on the Price/Forward Earnings ratio, RH is valued a bit cheaper than the industry average as 72.27% of the companies are valued more expensively.
RH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.09.
Industry RankSector Rank
PE 25.11
Fwd PE 13.42
RH Price Earnings VS Forward Price EarningsRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as RH.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.5
RH Per share dataRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RH's earnings are expected to grow with 49.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y57.8%
EPS Next 3Y49.48%

0

5. Dividend

5.1 Amount

RH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RH

NYSE:RH (10/22/2025, 8:04:00 PM)

After market: 180 +1.19 (+0.67%)

178.81

-6.89 (-3.71%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-11 2025-09-11/amc
Earnings (Next)12-10 2025-12-10/amc
Inst Owners89.63%
Inst Owner Change0.06%
Ins Owners18.49%
Ins Owner Change0.6%
Market Cap3.35B
Revenue(TTM)3.34B
Net Income(TTM)106.83M
Analysts72.86
Price Target261.45 (46.22%)
Short Float %19.55%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)115.8%
Min EPS beat(2)-11.15%
Max EPS beat(2)242.76%
EPS beat(4)1
Avg EPS beat(4)50.63%
Min EPS beat(4)-19.91%
Max EPS beat(4)242.76%
EPS beat(8)2
Avg EPS beat(8)-26.14%
EPS beat(12)5
Avg EPS beat(12)-13.06%
EPS beat(16)8
Avg EPS beat(16)-6.17%
Revenue beat(2)0
Avg Revenue beat(2)-3.45%
Min Revenue beat(2)-3.5%
Max Revenue beat(2)-3.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.7%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)-2.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.89%
Revenue beat(12)1
Avg Revenue beat(12)-3.04%
Revenue beat(16)2
Avg Revenue beat(16)-2.7%
PT rev (1m)-1.18%
PT rev (3m)-1.39%
EPS NQ rev (1m)-35.84%
EPS NQ rev (3m)-47.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.45%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-1.66%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 25.11
Fwd PE 13.42
P/S 1
P/FCF N/A
P/OCF 19.26
P/B N/A
P/tB N/A
EV/EBITDA 13.5
EPS(TTM)7.12
EY3.98%
EPS(NY)13.32
Fwd EY7.45%
FCF(TTM)-2.88
FCFYN/A
OCF(TTM)9.29
OCFY5.19%
SpS177.99
BVpS-2.18
TBVpS-14.1
PEG (NY)0.34
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.27%
ROE N/A
ROCE 9.53%
ROIC 8.46%
ROICexc 8.54%
ROICexgc 9.09%
OM 10.68%
PM (TTM) 3.2%
GM 44.61%
FCFM N/A
ROA(3y)4.87%
ROA(5y)7.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.73%
ROIC(5y)14.31%
ROICexc(3y)13.37%
ROICexc(5y)19.61%
ROICexgc(3y)14.37%
ROICexgc(5y)21.51%
ROCE(3y)12.08%
ROCE(5y)16.12%
ROICexgc growth 3Y-40.85%
ROICexgc growth 5Y-20.42%
ROICexc growth 3Y-40.13%
ROICexc growth 5Y-18.93%
OM growth 3Y-26.37%
OM growth 5Y-6.4%
PM growth 3Y-50.1%
PM growth 5Y-22.84%
GM growth 3Y-3.41%
GM growth 5Y1.47%
F-Score8
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.42
Cap/Depr 166.49%
Cap/Sales 6.83%
Interest Coverage 250
Cash Conversion 35.28%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.26
Altman-Z 1.33
F-Score8
WACC10.18%
ROIC/WACC0.83
Cap/Depr(3y)187.83%
Cap/Depr(5y)173.54%
Cap/Sales(3y)6.99%
Cap/Sales(5y)5.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)347.8%
EPS 3Y-41.01%
EPS 5Y-14.46%
EPS Q2Q%73.37%
EPS Next Y73.57%
EPS Next 2Y57.8%
EPS Next 3Y49.48%
EPS Next 5Y47.65%
Revenue 1Y (TTM)9.56%
Revenue growth 3Y-5.41%
Revenue growth 5Y3.74%
Sales Q2Q%8.38%
Revenue Next Year9.16%
Revenue Next 2Y9.65%
Revenue Next 3Y9.48%
Revenue Next 5Y8.41%
EBIT growth 1Y38.53%
EBIT growth 3Y-30.35%
EBIT growth 5Y-2.9%
EBIT Next Year70.77%
EBIT Next 3Y35.37%
EBIT Next 5Y26.15%
FCF growth 1Y-120.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.12%
OCF growth 3Y-70.44%
OCF growth 5Y-44.98%